Scadenza: 4 June 2020
Topic:
Strategies to convey accurate and up-to-date information on cell and gene
Programma:
Horizon 2020 SC1 "Health, demographic change and wellbeing"
Priority 1.2: Innovative health and care industry
Budget complessivo:
EUR 2 million
Status:
Closed
Quota finanziabile:
between EUR 1.5 and 2 million
Topic:
Strategies to convey accurate and up-to-date information on cell and gene
Who can participate:
Programme:
Horizon 2020 SC1 "Health, demographic change and wellbeing"
Priority 1.2: Innovative health and care industry
Consortium:
Status: Open
Total budget:
EUR 2 million
Funding rate:
between EUR 1.5 and 2 million
Notes:
Scope:
- Strategies to convey accurate and up-to-date information on cell and gene therapies using multiple contemporary modalities, including a website
- Provide expertise on human stem cells, regenerative medicine, genome editing and gene therapy
- Involve EMA, the Heads of Medicines Agencies network and/or EUnetHTA network
- Cover all stages of product development such as manufacturing guidelines and requirements, national and international regulations, data and clinical management as well as market approval and acceptability
Impact:
- Communicate to patients and the public objectively, accurately and transparently, the latest developments and actual treatments available in the field in order to avoid misconceptions.
- Better informed decision making by regulatory and healthcare authorities.
- Improved products development
